Scientists test new antibody shot that could block HIV
NCT ID NCT06585891
Summary
This early-stage study is testing the safety of a new antibody injection called CAP256J3LS in healthy adults. The antibody is designed to target and neutralize HIV, potentially preventing infection. Researchers are giving the antibody as either a single shot or three shots over several months to 24 participants, monitoring for side effects and how long the antibody stays in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.